These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12467995)

  • 1. Dynorphin-independent spinal cannabinoid antinociception.
    Gardell LR; Ossipov MH; Vanderah TW; Lai J; Porreca F
    Pain; 2002 Dec; 100(3):243-248. PubMed ID: 12467995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
    Houser SJ; Eads M; Embrey JP; Welch SP
    Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical cannabinoid antinociception: synergy with spinal sites.
    Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
    Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pronociceptive effects of spinal dynorphin promote cannabinoid-induced pain and antinociceptive tolerance.
    Gardell LR; Burgess SE; Dogrul A; Ossipov MH; Malan TP; Lai J; Porreca F
    Pain; 2002 Jul; 98(1-2):79-88. PubMed ID: 12098619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
    Welch SP
    J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception.
    Mason DJ; Lowe J; Welch SP
    Eur J Pharmacol; 1999 Aug; 378(3):237-48. PubMed ID: 10493099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
    Smith PA; Selley DE; Sim-Selley LJ; Welch SP
    Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord.
    Pugh G; Mason DJ; Combs V; Welch SP
    J Pharmacol Exp Ther; 1997 May; 281(2):730-7. PubMed ID: 9152379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
    Smith PB; Welch SP; Martin BR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1381-7. PubMed ID: 8138952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of kappa/dynorphin system in WIN 55,212-2 self-administration in mice.
    Mendizábal V; Zimmer A; Maldonado R
    Neuropsychopharmacology; 2006 Sep; 31(9):1957-66. PubMed ID: 16292318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical cannabinoid enhances topical morphine antinociception.
    Yesilyurt O; Dogrul A; Gul H; Seyrek M; Kusmez O; Ozkan Y; Yildiz O
    Pain; 2003 Sep; 105(1-2):303-8. PubMed ID: 14499448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of cannabinoid-induced inhibition of medullary dorsal horn neurons by a kappa-opioid receptor antagonist.
    Okada-Ogawa A; Kurose M; Meng ID
    Brain Res; 2010 Nov; 1359():81-9. PubMed ID: 20807519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice.
    Raffa RB; Stone DJ; Hipp SJ
    Neurosci Lett; 1999 Mar; 263(1):29-32. PubMed ID: 10218903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
    Yoon MH; Choi JI
    Anesthesiology; 2003 Sep; 99(3):701-7. PubMed ID: 12960556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
    Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH
    Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor.
    Nalwalk JW; Svokos K; Hough LB
    Eur J Pharmacol; 2006 Nov; 549(1-3):79-83. PubMed ID: 16989809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice.
    Reche I; Fuentes JA; Ruiz-Gayo M
    Eur J Pharmacol; 1996 Apr; 301(1-3):75-81. PubMed ID: 8773449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.